Long-term results after c. diff treatment: fecal transplant vs antibiotics
Part of Infections clinical trials.
This study is looking at people who were treated for C. diff (a serious gut infection) at Umeå University Hospital to see how they are doing years later. It compares people who got a fecal transplant (a treatment that restores healthy gut bacteria) with those who only took antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a confirmed C. diff infection between February 2016 and December 2024.
- You received treatment for C. diff at Umeå University Hospital (either antibiotics or a fecal transplant).
- The C. diff diagnosis met standard clinical criteria.
- No other stomach or intestinal infection was more likely to explain your symptoms at that time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
This study looks at “rescue” fecal microbiota transplantation (FMT), which replaces gut microbes using stool from a screened donor, for intestinal infections that have not improved with standard care. It may help patients whose infection keeps coming back or doesn’t respond to treatment.
This study tests a treatment called fecal microbiota transplantation (FMT), which puts healthy donor stool into your gut to help fight the bacteria that cause clostridium difficile infection. It may help clear the infection and restore your gut's natural balance.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.